chemoimmunotherapy Clinical Research Trials | TrialX

Loading...

Please select a valid location from the dropdown

Filter By

Clear all Advanced

Advanced Filters

Gender
Phase
Study Type
Sponsors
Accepts healthy volunteers
Online Trials
Age Group

Any (2)

Phase 2 (1)
Phase 3 (1)

Interventional (2)

Calithera Biosciences, Inc (1)
Epizyme, Inc. (1)

No (2)

No (2)

Adult (18+) (2)

I am/have/had

I am/have/hadsystemic therapy

I am/have/hadliquid biopsy

I am/have/hadstage iv non-small cell lung cancer

I am/have/hadadjuvant therapy

I am/have/hadbone marrow procedure

I am/have/hadlymphoma

I am/have/hadrenal function

I am/have/hadchemoimmunotherapy

I am/have/hadexperimental therapy

I am/have/hadBRAF

I am/have/hadproto-oncogene tyrosine-protein kinase ros

I am/have/hadbilateral oophorectomy

I am/have/hadhysterectomy

I am/have/hadtubal ligation

I am/have/hadcancer therapy

I am/have/hadfollicular lymphoma

I am/have/hadrenal function test

I am/have/hadmeasurable disease

I am/have/hadmetastasis

I am/have/hadsystemic chemotherapy

added new label for I am/have/had

more

I am looking for

I am looking formonoclonal antibodies

I am looking forrevlimid

I am looking forrituximab

I am looking forcarboplatin

I am looking forfolic acid

I am looking forbeta human chorionic gonadotropin

I am looking fortositumomab

I am looking forhepatitis b surface antigen

I am looking fornitrosoureas

I am looking forpembrolizumab

I am looking forhuman chorionic gonadotropin

I am looking foradjuvant

I am looking foribritumomab tiuxetan

I am looking formonoclonal protein

I am looking fortazemetostat

I am looking forpemetrexed

I am looking forvitamin b12 level

added new label for I am looking for

more

Advanced Filters

Loading...

Found 2 clinical trials

We call this “infoimagery”. It is unique to every trial and is generated based on a trials specific data eg. therapeutic area, study type, phase etc. and the centerwatch system associates the information to a matching set of related symbols and icons.

What's this?

Phase 3
For Seniors
For adults
Recruiting in 100s
Interventional Study
all
Recruiting

Study in Subjects With Relapsed/Refractory Follicular Lymphoma

This is a multicenter, double-blind, active-controlled, randomized, 3-stage, biomarker enrichment design featuring early futility stopping and sample-size re-estimation with safety run-in designed to evaluate the efficacy and safety of tazemetostat in combination with R2 in subjects with R/R FL, who have completed at least 1 prior systemic chemotherapy, immunotherapy, or …

monoclonal antibodies

systemic therapy

revlimid

rituximab

lymphoma

0 views
19 Feb, 2024

Phase 2
For Seniors
For adults
Recruiting in 100s
Interventional Study
all
Family Medicine
Recruiting

KEAPSAKE: A Study of Telaglenastat (CB-839) With Standard-of-Care Chemoimmunotherapy in 1L KEAP1/NRF2-Mutated Nonsquamous NSCLC

This is a Phase 2, randomized, multicenter, double-blind study of the glutaminase inhibitor telaglenastat with standard-of-care pembrolizumab and chemotherapy versus placebo with standard-of-care pembrolizumab and chemotherapy for first line treatment of metastatic disease in patients with KEAP1/NRF2-mutated, stage IV, nonsquamous, non-small cell lung cancer (NSCLC). The study primary endpoints are …

liquid biopsy

systemic therapy

stage iv non-small cell lung cancer

adjuvant therapy

carboplatin

0 views
19 Feb, 2024

Congrats! You have your own personal workspace now.

Learn more

© Copyright TrialX 2024 All rights reserved.